{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:19:49Z","timestamp":1789463989494,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T00:00:00Z","timestamp":1414972800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-799","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T12:02:23Z","timestamp":1415016143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Yukihiro","family":"Hirata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Yanaihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Urashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senya","family":"Matsufuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikou","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,3]]},"reference":[{"key":"5135_CR1","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6603116","volume":"94","author":"M Takano","year":"2006","unstructured":"Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T: Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer. 2006, 94: 1369-1374. 10.1038\/sj.bjc.6603116.","journal-title":"Br J Cancer"},{"key":"5135_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/IGC.0b013e3181ca1e16","volume":"20","author":"S Nishimura","year":"2010","unstructured":"Nishimura S, Tsuda H, Ito K, Takano M, Terai Y, Jobo T, Kigawa J, Sugiyama T, Yaegashi N, Aoki D: Differential expression of hypoxia-inducible protein 2 among different histological types of epithelial ovarian cancer and in clear cell adenocarcinomas. Int J Gynecol Cancer. 2010, 20: 220-226. 10.1111\/IGC.0b013e3181ca1e16.","journal-title":"Int J Gynecol Cancer"},{"key":"5135_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ol.2012.690","volume":"4","author":"Y Higashiura","year":"2012","unstructured":"Higashiura Y, Kajihara H, Shigetomi H, Kobayashi H: Identification of multiple pathways involved in the malignant transformation of endometriosis (Review). Oncol Lett. 2012, 4: 3-9.","journal-title":"Oncol Lett"},{"key":"5135_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/jcp.2006.040030","volume":"60","author":"DS Tan","year":"2007","unstructured":"Tan DS, Kaye S: Ovarian clear cell adenocarcinoma: a continuing enigma. J Clin Pathol. 2007, 60: 355-360.","journal-title":"J Clin Pathol"},{"key":"5135_CR5","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1038\/sj.bjc.6605406","volume":"101","author":"N Yokota","year":"2009","unstructured":"Yokota N, Koizume S, Miyagi E, Hirahara F, Nakamura Y, Kikuchi K, Ruf W, Sakuma Y, Tsuchiya E, Miyagi Y: Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer. 2009, 101: 2023-2029. 10.1038\/sj.bjc.6605406.","journal-title":"Br J Cancer"},{"key":"5135_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ygyno.2011.05.009","volume":"122","author":"YY Lee","year":"2011","unstructured":"Lee YY, Kim TJ, Kim MJ, Kim HJ, Song T, Kim MK, Choi CH, Lee JW, Bae DS, Kim BG: Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol. 2011, 122: 541-547. 10.1016\/j.ygyno.2011.05.009.","journal-title":"Gynecol Oncol"},{"key":"5135_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1126\/science.1196333","volume":"330","author":"S Jones","year":"2010","unstructured":"Jones S, Wang TL, Shih IM, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz LA, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N: Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010, 330: 228-231. 10.1126\/science.1196333.","journal-title":"Science"},{"key":"5135_CR8","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","volume":"163","author":"A Tsuchiya","year":"2003","unstructured":"Tsuchiya A, Sakamoto M, Yasuda J, Chuma M, Ohta T, Ohki M, Yasugi T, Taketani Y, Hirohashi S: Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol. 2003, 163: 2503-2512. 10.1016\/S0002-9440(10)63605-X.","journal-title":"Am J Pathol"},{"key":"5135_CR9","first-page":"1995","volume":"9","author":"A Hirasawa","year":"2003","unstructured":"Hirasawa A, Saito-Ohara F, Inoue J, Aoki D, Susumu N, Yokoyama T, Nozawa S, Inazawa J, Imoto I: Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin Cancer Res. 2003, 9: 1995-2004.","journal-title":"Clin Cancer Res"},{"key":"5135_CR10","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1158\/1078-0432.CCR-08-2403","volume":"15","author":"DS Tan","year":"2001","unstructured":"Tan DS, Lambros MB, Rayter S, Natrajan R, Vatcheva R, Gao Q, Marchi\u00f2 C, Geyer FC, Savage K, Parry S, Fenwick K, Tamber N, Mackay A, Dexter T, Jameson C, McCluggage WG, Williams A, Graham A, Faratian D, El-Bahrawy M, Paige AJ, Gabra H, Gore ME, Zvelebil M, Lord CJ, Kaye SB, Ashworth A, Reis-Filho JS: PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clin Cancer Res. 2001, 15: 2269-2280.","journal-title":"Clin Cancer Res"},{"key":"5135_CR11","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1158\/1078-0432.CCR-10-3314","volume":"17","author":"MS Anglesio","year":"2011","unstructured":"Anglesio MS, George J, Kulbe H, Friedlander M, Rischin D, Lemech C, Power J, Coward J, Cowin PA, House CM, Chakravarty P, Gorringe KL, Campbell IG, Okamoto A, Birrer MJ, Huntsman DG, de Fazio A, Kalloger SE, Balkwill F, Gilks CB, Bowtell DD, Australian Ovarian Cancer Study Group: IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clin Cancer Res. 2011, 17: 2538-2548. 10.1158\/1078-0432.CCR-10-3314.","journal-title":"Clin Cancer Res"},{"key":"5135_CR12","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature. 2005, 435: 834-838. 10.1038\/nature03702.","journal-title":"Nature"},{"key":"5135_CR13","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1373\/clinchem.2012.198176","volume":"59","author":"N Yanaihara","year":"2013","unstructured":"Yanaihara N, Harris CC: MicroRNA Involvement in Human Cancers. Clin Chem. 2013, 59: 1811-1812. 10.1373\/clinchem.2012.198176.","journal-title":"Clin Chem"},{"key":"5135_CR14","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006, 103: 2257-2261. 10.1073\/pnas.0510565103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5135_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","volume":"133","author":"F Meng","year":"2007","unstructured":"Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007, 133: 647-658. 10.1053\/j.gastro.2007.05.022.","journal-title":"Gastroenterology"},{"key":"5135_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ygyno.2008.09.040","volume":"112","author":"CM Ho","year":"2009","unstructured":"Ho CM, Lin MC, Huang SH, Huang CJ, Lai HC, Chien TY, Chang SF: PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas. Gynecol Oncol. 2009, 112: 307-313. 10.1016\/j.ygyno.2008.09.040.","journal-title":"Gynecol Oncol"},{"key":"5135_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ygyno.2005.09.047","volume":"101","author":"Y Hashiguchi","year":"2006","unstructured":"Hashiguchi Y, Tsuda H, Inoue T, Berkowitz RS, Mok SC: PTEN expression in clear cell adenocarcinoma of the ovary. Gynecol Oncol. 2006, 101: 71-75. 10.1016\/j.ygyno.2005.09.047.","journal-title":"Gynecol Oncol"},{"key":"5135_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1158\/1078-0432.CCR-10-1688","volume":"17","author":"DS Tan","year":"2011","unstructured":"Tan DS, Iravani M, McCluggage WG, Lambros MB, Milanezi F, Mackay A, Gourley C, Geyer FC, Vatcheva R, Millar J, Thomas K, Natrajan R, Savage K, Fenwick K, Williams A, Jameson C, El-Bahrawy M, Gore ME, Gabra H, Kaye SB, Ashworth A, Reis-Filho JS: Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas. Clin Cancer Res. 2011, 17: 1521-1534. 10.1158\/1078-0432.CCR-10-1688.","journal-title":"Clin Cancer Res"},{"key":"5135_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000012137","volume":"59","author":"Y Suehiro","year":"2000","unstructured":"Suehiro Y, Sakamoto M, Umayahara K, Iwabuchi H, Sakamoto H, Tanaka N, Takeshima N, Yamauchi K, Hasumi K, Akiya T, Sakunaga H, Muroya T, Numa F, Kato H, Tenjin Y, Sugishita T: Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas. Oncology. 2000, 59: 50-56.","journal-title":"Oncology"},{"key":"5135_CR20","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1158\/1078-0432.CCR-09-2105","volume":"16","author":"KT Kuo","year":"2010","unstructured":"Kuo KT, Mao TL, Chen X, Feng Y, Nakayama K, Wang Y, Glas R, Ma MJ, Kurman RJ, Shih IM, Wang TL: DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma. Clin Cancer Res. 2010, 16: 1997-2008. 10.1158\/1078-0432.CCR-09-2105.","journal-title":"Clin Cancer Res"},{"key":"5135_CR21","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"GA Calin","year":"2004","unstructured":"Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004, 101: 2999-3004. 10.1073\/pnas.0307323101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5135_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","volume":"9","author":"N Yanaihara","year":"2006","unstructured":"Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006, 9: 189-198. 10.1016\/j.ccr.2006.01.025.","journal-title":"Cancer Cell"},{"key":"5135_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5732\/cjc.30.0371","volume":"30","author":"E Lindsey","year":"2011","unstructured":"Lindsey E, Becker B, Yong L: Apoptosis and the target genes of miR-21. Chin J Cancer. 2011, 30: 371-380. 10.5732\/cjc.011.10132.","journal-title":"Chin J Cancer"},{"key":"5135_CR24","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-09-2990","volume":"16","author":"S Zhang","year":"2010","unstructured":"Zhang S, Dihua Y: PI (3) King Apart PTEN's Role in Cancer. Clin Cancer Res. 2010, 16: 4325-4330. 10.1158\/1078-0432.CCR-09-2990.","journal-title":"Clin Cancer Res"},{"key":"5135_CR25","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1158\/0008-5472.CAN-05-3987","volume":"66","author":"DS Michaud","year":"2006","unstructured":"Michaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, Crawford ED, Hsing A, Huang WY, Hayes RB: Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res. 2006, 66: 4525-4530. 10.1158\/0008-5472.CAN-05-3987.","journal-title":"Cancer Res"},{"key":"5135_CR26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3892\/ijo.2012.1533","volume":"41","author":"N Yanaihara","year":"2012","unstructured":"Yanaihara N, Anglesio MS, Ochiai K, Hirata Y, Saito M, Nagata C, Iida Y, Takakura S, Yamada K, Tanaka T, Okamoto A: Cytokine gene expression signature in ovarian clear cell carcinoma. Int J Oncol. 2012, 41: 1094-10100.","journal-title":"Int J Oncol"},{"key":"5135_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","volume":"39","author":"D Iliopoulos","year":"2010","unstructured":"Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell. 2010, 39: 493-506. 10.1016\/j.molcel.2010.07.023.","journal-title":"Mol Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-799.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-799\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-799.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:21:04Z","timestamp":1630567264000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5135"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-799","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,3]]},"assertion":[{"value":"1 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"799"}}